These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 12895230)
21. Vasculitis-susceptible genes in mice with a deficit in Fas-mediated apoptosis. Nose M; Terada M; Nishihara M; Kamogawa J; Miyazaki T; Mori S; Nishimura M; Wang Y; Kamoto T; Hiai H Int J Cardiol; 1998 Oct; 66 Suppl 1():S37-41; discussion S43. PubMed ID: 9951801 [TBL] [Abstract][Full Text] [Related]
22. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice. Miyashima S; Nagata N; Nakagawa T; Hosaka N; Takeuchi K; Ogawa R; Ikehara S J Immunol; 1996 Jan; 156(1):79-84. PubMed ID: 8598497 [TBL] [Abstract][Full Text] [Related]
23. Crucial Fas-Fas ligand interaction in spontaneous acceptance of hepatic allografts in mice. Uchiyama H; Kishihara K; Minagawa R; Hashimoto K; Sugimachi K; Nomoto K Immunology; 2002 Apr; 105(4):450-7. PubMed ID: 11985665 [TBL] [Abstract][Full Text] [Related]
24. Bone marrow transplantation: a new strategy for intractable diseases. Ikehara S Drugs Today (Barc); 2002 Feb; 38(2):103-11. PubMed ID: 12532188 [TBL] [Abstract][Full Text] [Related]
25. Mice deficient in fas ligand (gld) or fas (lpr) show few alterations in granulopoiesis. Fecho K; Bentley SA; Cohen PL Cell Immunol; 1998 Aug; 188(1):19-32. PubMed ID: 9743554 [TBL] [Abstract][Full Text] [Related]
26. Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells. Mittelstadt PR; Ashwell JD J Biol Chem; 1999 Jan; 274(5):3222-7. PubMed ID: 9915863 [TBL] [Abstract][Full Text] [Related]
27. Comparison of wasting syndrome in [MRL lpr/lpr-->MRL +/+] chimera and graft versus host disease in [B10.D2-->BALB/c] chimera and an attempt to transfer the wasting syndrome in [MRL lpr/lpr-->MRL +/+] to MRL +/+ mice. Aihara M; Aihara Y; Nakajima H J Dermatol Sci; 1994 Apr; 7(2):107-18. PubMed ID: 7914743 [TBL] [Abstract][Full Text] [Related]
28. Thymic microenvironmental abnormalities in MRL/MP-lpr/lpr, BXSB/MpJ Yaa and C3H HeJ-gld/gld mice. Takeoka Y; Yoshida SH; Van de Water J; Boyd R; Suehiro S; Ansari AA; Gershwin ME J Autoimmun; 1995 Apr; 8(2):145-61. PubMed ID: 7612145 [TBL] [Abstract][Full Text] [Related]
29. Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease. van den Brink MR; Moore E; Horndasch KJ; Crawford JM; Murphy GF; Burakoff SJ Transplantation; 2000 Jul; 70(1):184-91. PubMed ID: 10919598 [TBL] [Abstract][Full Text] [Related]
30. Apoptosis with FasL+ cell infiltration in the periphery and thymus of corrected autoimmune mice. Kobata T; Takasaki K; Asahara H; Hong NM; Masuko-Hongo K; Kato T; Hirose S; Shirai T; Kayagaki N; Yagita H; Okumura K; Nishioka K Immunology; 1997 Oct; 92(2):206-13. PubMed ID: 9415028 [TBL] [Abstract][Full Text] [Related]
31. Fas on renal parenchymal cells does not promote autoimmune nephritis in MRL mice. Wada T; Schwarting A; Kinoshita K; Naito T; Griffiths RC; Coffman TM; Kelley VR Kidney Int; 1999 Mar; 55(3):841-51. PubMed ID: 10027921 [TBL] [Abstract][Full Text] [Related]
32. Host modifier genes affect mouse autoimmunity induced by the lpr gene. Wang Y; Nose M; Kamoto T; Nishimura M; Hiai H Am J Pathol; 1997 Dec; 151(6):1791-8. PubMed ID: 9403730 [TBL] [Abstract][Full Text] [Related]
33. Genetic dissection of the complex pathological manifestations of collagen disease in MRL/lpr mice. Nakatsuru S; Terada M; Nishihara M; Kamogawa J; Miyazaki T; Qu WM; Morimoto K; Yazawa C; Ogasawara H; Abe Y; Fukui K; Ichien G; Ito MR; Mori S; Nakamura Y; Nose M Pathol Int; 1999 Nov; 49(11):974-82. PubMed ID: 10594844 [TBL] [Abstract][Full Text] [Related]
34. Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT). Karussis DM; Vourka-Karussis U; Lehmann D; Abramsky O; Ben-Nun A; Slavin S Clin Exp Immunol; 1995 Apr; 100(1):111-7. PubMed ID: 7697909 [TBL] [Abstract][Full Text] [Related]
36. Resistance to lymphoid engraftment in lpr recipients of normal bone marrow: characterization of chimeric stem cell, monocyte and peripheral lymphoid lineages. Glaser RM; Marshak-Rothstein A Eur J Immunol; 1990 Sep; 20(9):1917-25. PubMed ID: 2209698 [TBL] [Abstract][Full Text] [Related]
37. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Ikehara S; Yasumizu R; Inaba M; Izui S; Hayakawa K; Sekita K; Toki J; Sugiura K; Iwai H; Nakamura T Proc Natl Acad Sci U S A; 1989 May; 86(9):3306-10. PubMed ID: 2654943 [TBL] [Abstract][Full Text] [Related]
38. Correction of gld autoimmunity by co-infusion of normal bone marrow suggests that gld is a mutation of the Fas ligand gene. Sobel ES; Kakkanaiah VN; Cohen PL; Eisenberg RA Int Immunol; 1993 Oct; 5(10):1275-8. PubMed ID: 7505611 [TBL] [Abstract][Full Text] [Related]
39. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus. Satoh M; Weintraub JP; Yoshida H; Shaheen VM; Richards HB; Shaw M; Reeves WH J Immunol; 2000 Jul; 165(2):1036-43. PubMed ID: 10878381 [TBL] [Abstract][Full Text] [Related]
40. Cellular interactions in the lpr and gld models of systemic autoimmunity. Sobel ES Adv Dent Res; 1996 Apr; 10(1):76-80. PubMed ID: 8934931 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]